National HealthCare Corporation (NHC) Income Statement Analysis

See more : Goyal Aluminiums Limited (GOYALALUM.NS) Income Statement Analysis – Financial Results

Complete financial analysis of National HealthCare Corporation (NHC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of National HealthCare Corporation, a leading company in the Medical – Care Facilities industry within the Healthcare sector.

You may be interested

R.P.P. Infra Projects Limited (RPPINFRA.NS) Income Statement Analysis – Financial Results
TCL Technology Group Corporation (000100.SZ) Income Statement Analysis – Financial Results
Arrowhead Seperation Engineeri (ARROWHEAD.BO) Income Statement Analysis – Financial Results
Alembic Pharmaceuticals Limited (APLLTD.NS) Income Statement Analysis – Financial Results
Darshan Orna Limited (DARSHANORNA.BO) Income Statement Analysis – Financial Results

National HealthCare Corporation (NHC)

Industry: Medical - Care Facilities

Sector: Healthcare

Website: https://www.nhccare.com

About National HealthCare Corporation

National HealthCare Corporation operates, manages, and provides services to skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and a behavioral health hospital. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. The company's medical specialty units comprise memory care units and sub-cute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living centers offer personal care services and assistance with general activities of daily living, such as dressing, bathing, meal preparation, and medication management. It also offers behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders. In addition, it provides health care programs that offer skilled services, such as infusion, wound care and physical, occupational, and speech therapies; hospice care services; operates pharmacies; offers management, accounting, financial, and insurance services; and leases its properties to third party operators. As of February 18, 2022, the company operated 75 skilled nursing facilities with 9,473 beds, 24 assisted living facilities, five independent living facilities, one behavioral health hospital, 34 homecare agencies, and 28 hospice agencies. National HealthCare Corporation was founded in 1971 and is based in Murfreesboro, Tennessee.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992	1991
Revenue	1.14B	1.07B	1.01B	980.71M	996.38M	980.35M	963.90M	923.58M	906.62M	871.68M	788.96M	761.00M	773.24M	720.65M	668.22M	633.21M	598.03M	562.96M	542.38M	521.83M	472.86M	458.25M	419.97M	462.42M	440.15M	441.20M	463.48M	386.30M	349.40M	298.90M	269.90M	216.40M	184.60M
Cost of Revenue	712.34M	686.17M	666.06M	609.31M	592.83M	582.72M	572.04M	548.01M	532.74M	510.25M	453.56M	426.93M	428.67M	400.27M	558.85M	538.51M	502.09M	157.66M	150.16M	149.56M	129.72M	127.05M	111.72M	119.59M	121.35M	163.50M	140.00M	123.30M	107.00M	98.80M	80.20M	72.90M	146.10M
Gross Profit	429.20M	388.11M	344.88M	371.41M	403.55M	397.63M	391.85M	375.57M	373.89M	361.43M	335.40M	334.07M	344.57M	320.38M	109.37M	94.70M	95.94M	405.29M	392.22M	372.27M	343.15M	331.21M	308.25M	342.83M	318.80M	277.70M	323.48M	263.00M	242.40M	200.10M	189.70M	143.50M	38.50M
Gross Profit Ratio	37.60%	71.37%	37.71%	37.87%	40.50%	40.56%	40.84%	40.86%	41.24%	41.46%	42.51%	43.92%	74.35%	16.52%	16.37%	17.02%	16.04%	71.99%	72.31%	71.34%	72.57%	72.28%	73.40%	74.14%	72.43%	62.94%	69.80%	67.66%	69.06%	66.95%	70.29%	66.31%	20.86%
Research & Development	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	41.53M	40.98M	40.82M	40.49M	40.52M	40.92M	40.37M	41.29M	39.97M	39.73M	39.45M	39.36M	39.74M	38.09M	32.35M	31.45M	40.21M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	41.53M	40.98M	40.82M	40.49M	40.52M	40.92M	40.37M	41.29M	39.97M	39.73M	39.45M	39.36M	39.74M	38.09M	32.35M	31.45M	40.21M	343.17M	327.54M	317.15M	295.40M	279.95M	268.20M	304.35M	289.02M	243.30M	258.30M	209.60M	189.00M	157.70M	128.50M	111.00M	0.00
Other Expenses	330.54M	315.24M	253.14M	282.76M	314.00M	300.63M	297.38M	273.74M	266.79M	253.69M	223.87M	226.48M	225.98M	224.67M	26.15M	25.69M	17.01M	14.17M	15.46M	13.77M	12.38M	12.37M	12.73M	14.44M	10.39M	12.10M	15.00M	13.20M	15.40M	13.60M	12.00M	10.40M	7.60M
Operating Expenses	372.07M	356.22M	293.95M	323.25M	354.51M	341.55M	337.74M	315.03M	306.76M	293.42M	263.32M	265.83M	265.72M	262.76M	58.50M	57.14M	57.21M	357.34M	343.00M	330.91M	307.78M	292.32M	280.93M	318.79M	299.41M	255.40M	273.30M	222.80M	204.40M	171.30M	140.50M	121.40M	7.60M
Cost & Expenses	1.08B	1.04B	960.02M	932.56M	947.35M	924.27M	909.79M	863.04M	839.50M	803.67M	716.88M	692.77M	694.39M	663.03M	617.35M	595.66M	559.31M	515.01M	493.16M	480.48M	437.50M	419.36M	392.65M	438.38M	420.76M	418.90M	413.30M	346.10M	311.40M	270.10M	220.70M	194.30M	153.70M
Interest Income	8.38M	5.13M	4.67M	5.80M	7.19M	7.18M	6.17M	5.48M	5.49M	4.55M	5.24M	4.62M	4.98M	5.38M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Interest Expense	324.00K	563.00K	845.00K	1.40M	3.14M	4.70M	4.89M	3.94M	2.61M	2.17M	331.00K	455.00K	443.00K	513.00K	716.00K	873.00K	1.17M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation & Amortization	42.03M	40.49M	40.67M	42.02M	42.42M	41.89M	42.65M	39.02M	37.11M	34.38M	28.55M	29.79M	28.90M	27.14M	25.43M	24.82M	17.01M	12.71M	14.15M	12.44M	11.21M	11.15M	11.87M	14.44M	10.39M	12.10M	15.00M	13.20M	15.40M	13.60M	12.00M	10.40M	7.60M
EBITDA	131.10M	68.28M	191.56M	95.84M	133.57M	121.48M	122.09M	123.17M	125.00M	121.74M	131.05M	123.73M	128.73M	108.62M	93.80M	78.98M	90.41M	62.12M	64.68M	55.12M	47.75M	51.26M	40.05M	38.48M	29.77M	34.40M	65.18M	53.40M	53.40M	42.40M	61.20M	32.50M	38.50M
EBITDA Ratio	11.48%	6.97%	11.72%	12.22%	12.18%	12.27%	12.63%	13.29%	13.79%	13.97%	15.95%	15.96%	13.79%	11.92%	11.53%	12.17%	3.52%	9.74%	12.11%	10.56%	-0.50%	1.83%	-0.37%	8.32%	6.76%	14.14%	14.07%	13.74%	15.21%	14.19%	22.68%	15.02%	20.86%
Operating Income	57.13M	31.90M	50.93M	48.16M	49.04M	56.08M	54.11M	60.54M	67.13M	68.01M	72.08M	68.24M	78.85M	57.63M	50.87M	37.55M	38.73M	47.95M	49.22M	41.35M	35.37M	38.89M	27.32M	24.04M	19.39M	22.30M	50.18M	40.20M	38.00M	28.80M	49.20M	22.10M	30.90M
Operating Income Ratio	5.00%	2.97%	7.69%	7.93%	7.92%	5.72%	5.60%	6.53%	7.40%	7.80%	9.14%	8.67%	10.00%	8.05%	7.61%	8.35%	6.48%	8.52%	9.07%	7.92%	7.48%	8.49%	6.51%	5.20%	4.40%	5.05%	10.85%	10.34%	10.83%	9.64%	18.23%	10.21%	16.74%
Total Other Income/Expenses	31.60M	-4.67M	99.11M	4.27M	38.98M	18.81M	20.44M	19.67M	18.15M	17.18M	30.10M	25.25M	20.53M	23.34M	16.78M	15.74M	33.51M	6.33M	-2.53M	-1.30M	-2.08M	-11.44M	-5.16M	-6.88M	-5.35M	-32.40M	-12.98M	-40.20M	-38.00M	-28.80M	-49.20M	-22.10M	-30.90M
Income Before Tax	88.74M	27.23M	150.04M	52.42M	88.02M	74.88M	74.55M	80.21M	85.27M	85.19M	102.18M	93.48M	99.38M	80.97M	67.66M	53.29M	72.23M	54.28M	46.69M	40.06M	33.29M	27.45M	22.16M	17.16M	14.04M	-10.10M	37.20M	0.00	0.00	0.00	0.00	0.00	0.00
Income Before Tax Ratio	7.77%	2.53%	14.84%	5.35%	8.83%	7.64%	7.71%	8.66%	9.41%	9.77%	12.95%	11.99%	12.65%	11.32%	10.12%	8.21%	12.08%	9.64%	8.61%	7.68%	7.04%	5.99%	5.28%	3.71%	3.19%	-2.29%	8.03%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Income Tax Expense	23.45M	7.25M	10.95M	10.43M	20.04M	16.19M	18.87M	29.67M	32.13M	31.82M	37.56M	34.18M	34.39M	28.27M	27.61M	16.92M	26.79M	17.54M	18.06M	16.08M	13.34M	11.01M	8.96M	6.94M	5.65M	-3.70M	200.00K	0.00	0.00	0.00	0.00	0.00	0.00
Net Income	66.80M	22.45M	138.59M	41.87M	68.21M	58.96M	56.21M	50.54M	53.14M	53.37M	64.61M	59.30M	64.99M	52.70M	40.05M	36.37M	45.45M	36.74M	28.64M	23.97M	19.95M	16.44M	13.20M	10.22M	8.38M	-6.40M	37.00M	29.30M	21.10M	15.90M	37.60M	9.50M	17.70M
Net Income Ratio	5.85%	2.09%	13.71%	4.27%	6.85%	6.01%	5.81%	5.45%	5.86%	6.12%	8.19%	7.61%	8.28%	7.36%	5.99%	5.60%	7.60%	6.53%	5.28%	4.59%	4.22%	3.59%	3.14%	2.21%	1.90%	-1.45%	7.98%	7.54%	6.01%	5.32%	13.93%	4.39%	9.59%
EPS	4.36	1.46	9.03	2.74	4.47	3.87	3.70	3.34	3.34	3.24	4.05	3.65	4.09	3.22	2.31	2.16	3.47	2.99	0.34	2.05	1.72	1.43	1.17	0.89	0.73	-0.58	4.17	3.48	2.67	2.02	4.85	1.28	2.45
EPS Diluted	4.34	1.45	8.99	2.72	4.44	3.87	3.69	3.32	3.20	3.14	3.87	3.57	3.96	3.22	2.31	2.11	3.36	2.85	0.24	1.95	1.65	1.37	1.13	0.89	0.73	-0.58	3.58	2.97	2.32	1.80	4.05	1.23	2.45
Weighted Avg Shares Out	15.31M	15.41M	15.35M	15.31M	15.27M	15.22M	15.19M	15.13M	13.89M	13.82M	13.83M	13.85M	13.77M	13.67M	13.56M	12.83M	12.56M	12.29M	12.24M	11.69M	11.61M	11.51M	11.27M	11.45M	11.42M	11.12M	8.87M	8.42M	7.90M	7.87M	7.75M	7.42M	7.22M
Weighted Avg Shares Out (Dil)	15.38M	15.45M	15.42M	15.37M	15.36M	15.24M	15.22M	15.21M	14.49M	14.22M	16.70M	16.60M	16.41M	13.68M	13.58M	13.13M	12.99M	12.89M	12.79M	12.29M	12.06M	11.97M	11.68M	11.47M	11.42M	11.12M	10.34M	9.87M	9.09M	8.83M	9.28M	7.72M	7.22M

Coronavirus - all you need to know as 'pandemic potential' virus found in pigs

June 30, 2020mirror.co.uk

A new flu virus with 'pandemic potential', named G4 EA H1N1, has been found in pigs in China, with scientists warning it thrives and multiplies in the cells that grow in the human airway

Coronavirus - all you need to know as 'pandemic potential' virus found in pigs

June 30, 2020mirror.co.uk

A new flu virus with 'pandemic potential', named G4 EA H1N1, has been found in pigs in China, with scientists warning it thrives and multiplies in the cells that grow in the human airway

Panic at Beijing’s border as county locked down, 7.69 million tested

June 29, 2020hindustantimes.com

Following the lockdown rules that were implemented in the first pandemic epicentre, the central Chinese centre of Wuhan, no non-residents will be allowed to enter communities or villages.

China puts 400,000 people into lockdown near Beijing amid surge in coronavirus cases

June 29, 2020independent.co.uk

Anxin county in Hubei province will be ‘fully enclosed and controlled’, officials say

Health News Roundup: CanSino's COVID-19 vaccine candidate approved for military use in China; Australia sees biggest daily rise in COVID-19 cases in two months and more

June 29, 2020devdiscourse.com

Australia sees biggest daily rise in COVID-19 cases in two months Australia's second most populous state said on Monday it is considering reimposing social distancing restrictions after the country reported its biggest one-day rise in new coronavirus infections in more...